Clinical Trial Supply 2020 – A virtual conference

10th September 2020 (Last Updated November 18th, 2020 19:19)

Sponsored by Arena International Sponsored by Visit Company

2020 will see the return of the Clinical Trial Supply series to a new and innovative online platform for this two-day event where pharma, large and small, alongside biotechs will have the opportunity to discuss, debate and consider new technologies and processes to streamline supply chain operations.

This meeting promises to showcase best practices and techniques which are translatable into practice.

Register today for free to ensure you don’t miss out on:

  • Live Q&A discussions with keynote speakers, including with Derrick L. Kearney from US Customs and Border Protection – get your questions answered!
  • Fireside chat discussion on the clinical to commercial transition led by Merck Pharmaceuticals
  • Get the latest information on new technologies such as blockchain, AI and remote trails with real-life use cases from companies that are using them
  • Up to date Trial Management tips with discussions on Clinical Trial Supply best practices during Covid and case studies on how your colleagues made remote working work for them

Visit our website to learn more about the event and book your place now!

Free Report

Improving Clinical Trials

Enter your details here to register for the event and receive your free report.

FREE REPORT: How RWS and Clinical Ink Worked Together to Streamline Processes, Drive Efficiency, and Generate Cost-Savings for Clinical Trial Sponsors.

Enter your details here to receive your free report:

By clicking the “Submit” button above, you accept the Terms & Conditions and acknowledge that your data will be used as described in the Arena Healthcare Privacy Policy.

We will also collect and use the information you provide for carefully considered and specific purposes, where we believe we have a legitimate interest in doing so, for example to send you communications about similar products and services we offer. We will always give you an option to opt out of any future communications from us. You can find out more about our legitimate interest activity in our privacy policy here. ‘We’ includes Verdict Media Limited and other GlobalData brands as detailed here.